![Johanne Kaplan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Johanne Kaplan
Corporate Officer/Principal chez
PROMIS NEUROSCIENCES, INC.
Fortune : 81 308 $ au 31/08/2026
Profil
Johanne Kaplan is currently Chief Development Officer at ProMIS Neurosciences, Inc., a position held since 2016.
Formerly, Dr. Kaplan was Associate at Smithkline Beecham Plc from 1990 to 1992, Vice President-Research at Genzyme Corp.
from 2005 to 2015, and Chief Scientific Officer at Epiva Biosciences, Inc. from 2015 to 2016.
Dr. Kaplan earned a doctorate from McGill University in 1986.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 05/08/2026 | 6 221 ( 0,07% ) | 81 308 $ | 31/08/2026 |
Postes actifs de Johanne Kaplan
| Sociétés | Poste | Début |
|---|---|---|
| PROMIS NEUROSCIENCES, INC. | Corporate Officer/Principal | 21/07/2016 |
Anciens postes connus de Johanne Kaplan
| Sociétés | Poste | Fin |
|---|---|---|
Epiva Biosciences, Inc.
 Epiva Biosciences, Inc. BiotechnologyHealth Technology Develops immunobiotic therapeutics | Directeur Technique/Scientifique/R&D | 01/05/2016 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | 01/07/2015 |
Smithkline Beecham Plc
 Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Develops and manufactures pharmaceutical products | Corporate Officer/Principal | 01/06/1992 |
Formation de Johanne Kaplan
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
96
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Smithkline Beecham Plc
Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
McGill University
 McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ProMIS Neurosciences, Inc.
 ProMIS Neurosciences, Inc. BiotechnologyHealth Technology Discovers and develops precision medicine solutions for the treatment of neurodegenerative & misfolded protein diseases | Health Technology |
Epiva Biosciences, Inc.
Epiva Biosciences, Inc. BiotechnologyHealth Technology Develops immunobiotic therapeutics | Health Technology |
